CAPECITABINE AND OXALIPLATIN (CAPOX) PLUS CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA WHO PROGRESSED AFTER OXALIPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Petrovic, Z. [1 ]
机构：
[1] VMA, Gastroenterol Clin, Dept Gi Oncol, Belgrade, Serbia
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [1] Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
    Souglakos, J.
    Kalykaki, A.
    Vamvakas, L.
    Androulakis, N.
    Kalbakis, K.
    Agelaki, S.
    Vardakis, N.
    Tzardi, M.
    Kotsakis, A. P.
    Gioulbasanis, J.
    Tsetis, D.
    Sfakiotaki, G.
    Chatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 305 - 310
  • [2] Cetuximab with oxaliplatin and capecitabine (CAPOX)in patients with metastatic colorectal cancer (mCRC) refractory to standard chemotherapy.
    Grothe, W
    Arnold, D
    Peinert, S
    Voigt, W
    Loeffler, LM
    Siewczynski, R
    Steps, G
    Boehme, J
    Graeven, U
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 288S - 288S
  • [3] Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 319 - 329
  • [4] Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Beatty, Gregory L.
    Giantonio, Bruce J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 683 - 688
  • [5] ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED CHEMOTHERAPY ON LIVER AND SPLEEN SIZE AND THROMBOCYTOPENIA IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Lee, Victor
    Fang, Weijia
    Lam, K. O.
    Choi, Cheukwai
    Ng, Sherry
    Ho, Garrett
    Cheng, Thomas
    Liu, Rico
    Leung, T. W.
    Kwong, D. L. W.
    Zheng, Shusen
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [6] Oxaliplatin and capecitabine (CAPOX) is active and feasible for irinotecan refractory metastatic colorectal carcinoma (MCRC)
    Munoz, Alberto
    Viteri, Ainboa
    Rubio, Itziar
    Alvarez, Aitor
    Mane, Joan M.
    Pardo, Marta
    Fernandez, Ricardo
    Lopez-Argumedo, Gonzalo
    Barcelo, Ramon
    Lopez-Vivanco, Guillermo
    ANNALS OF ONCOLOGY, 2004, 15 : 92 - 92
  • [7] Splenomegaly During Oxaliplatin-based Chemotherapy for Colorectal Carcinoma
    Jung, Eun-Joo
    Ryu, Chun-Geun
    Kim, Gangmi
    Kim, Su Ran
    Park, Hee Sun
    Kim, Young Jun
    Hwang, Dae-Yong
    ANTICANCER RESEARCH, 2012, 32 (08) : 3357 - 3362
  • [8] Capecitabine plus oxaliplatin in metastatic colorectal cancer
    Cassidy, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) : 5043 - 5045
  • [9] A meta analysis of cetuximab plus oxaliplatin based chemotherapy regimen for metastatic colorectal cancer
    Zhu, Y. L.
    Lou, J.
    Guo, J. Y.
    Huang, Z.
    Lv, S. W.
    INDIAN JOURNAL OF CANCER, 2014, 51 (07) : 113 - 116
  • [10] Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
    Berretta, Massimiliano
    Zanet, Ernesto
    Nasti, Guglielmo
    Lleshi, Arben
    Frustaci, Sergio
    Fiorica, Francesco
    Bearz, Alessandra
    Talamini, Renato
    Lestuzzi, Chiara
    Lazzarini, Renzo
    Fisichella, Rossella
    Cannizzaro, Renato
    Iaffaioli, Rosario Vincenzo
    Berretta, Salvatore
    Tirelli, Umberto
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 271 - 275
12345